Results 111 to 120 of about 12,533 (219)

Prevention of infectious diseases in athletes. [PDF]

open access: yes, 2007
The sports medicine physician may face challenging issues regarding infectious diseases when dealing with teams or highly competitive athletes who have difficulties taking time off to recover.
d'Hemecourt, Pierre, Luke, Anthony
core  

Competition, coinfection and strain replacement in models of Bordetella Pertussis [PDF]

open access: yes, 2015
Ayabina, D   +4 more
core   +1 more source

Comparative safety and immunogenicity of an acellular versus whole- cell pertussis component of Diphteria-Tetanus-Pertussis vaccines in senegalese infants [PDF]

open access: yes, 1996
A diphtheria and tetanus toxoid two-component acellular pertussis vaccine (DTaP), consisting of 25 microg glutaraldehyde-detoxified pertussis toxin (PT) and 25 microg native filamentous hemagglutinin (FHA), was compared with diphtheria and tetanus toxoid
Cadoz, M.   +5 more
core  

The Effectiveness of California Assembly Bill 2109: Personal Belief Exemptions for Kindergarten Immunizations [PDF]

open access: yes, 2016
The numbers of vaccine preventable diseases (VPDs) in the United States has declined with the development, administration, and effectiveness of vaccines during the 1970s and 1980s.
Goishi-Bessey, Lilli Shizuka
core   +1 more source

More than 10 years after introduction of an acellular pertussis vaccine in infancy: a cross-sectional serosurvey of pertussis in the Netherlands. [PDF]

open access: yesLancet Reg Health Eur, 2021
Versteegen P   +6 more
europepmc   +1 more source

Immunologic profiling of the infant immune response to whole-cell and acellular pertussis vaccines

open access: yesnpj Vaccines
Despite robust antibody responses, immunity induced by acellular pertussis vaccine (DTaP) wanes over time and risk of pertussis seems to be lower in children who receive whole-cell vaccine (DTP) as their first dose.
C. Buddy Creech   +15 more
doaj   +1 more source

Home - About - Disclaimer - Privacy